Ładuje się......
AB 26. Comparison of pharmacokinetics of Moxifloxacin between patients with drug-resistant and multi-drug resistant pulmonary tuberculosis
BACKGROUND: Moxifloxacin is a potent bactericidal and sterilizing antitubercular drug that is currently used as part of the therapeutic regimen in cases of drug resistant (DR) and multi-drug resistant (MDR) tuberculosis (TB). According to previous reports rifampicin reduces Moxifloxacin levels by 30...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Pioneer Bioscience Publishing Company
2012
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3537437/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2012.s026 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|